Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer

ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to assess the role of four selected single nucleotide polymorphisms (SNPs) in ERCC5 and their linkage disequilibrium associated wit...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2023-01, Vol.12, p.1091514-1091514
Main Authors: Khan, Iqra, Masood, Nosheen, Yasmin, Azra
Format: Article
Language:English
Subjects:
breast cancer
ERCC5 gene
linkage disequilibrium
Oncology
polymorphism
survival analyses
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c417t-d7b8bdeaa07f4b9611014001284f214d8c1107bfc911b05039a0dc1157ed1eb3
container_end_page 1091514
container_issue
container_start_page 1091514
container_title Frontiers in oncology
container_volume 12
creator Khan, Iqra
Masood, Nosheen
Yasmin, Azra
description ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to assess the role of four selected single nucleotide polymorphisms (SNPs) in ERCC5 and their linkage disequilibrium associated with survival analysis and clinical outcomes in breast cancer. Four SNPs (rs751402, rs17655, rs2094258, and rs873601) of the ERCC5 gene were analyzed using the PCR-RFLP technique, followed by sequencing in 430 breast cancer (BC) cases and 430 cancer-free individuals. Statistical analysis was performed using MedCalc 17 and SPSS version 24, while bioinformatic analysis of linkage disequilibrium was performed using Haploview software 4.2. Multivariate analysis showed that the rs751402 and rs2094258 polymorphisms were significantly associated with an elevated risk of BC (P < 0.001), while the other two SNPs, rs17655 and rs873601, did not show any association (P > 0.001). Survival analysis revealed that rs751402 and rs2094258 had longer overall survival periods (P
doi_str_mv 10.3389/fonc.2022.1091514
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f4b40214690a46259a0c895a31c7bdd7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f4b40214690a46259a0c895a31c7bdd7</doaj_id><sourcerecordid>2768813272</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-d7b8bdeaa07f4b9611014001284f214d8c1107bfc911b05039a0dc1157ed1eb3</originalsourceid><addsrcrecordid>eNpVkstqGzEYhYfS0oQ0D9BN0bIbO7rNRZtCMWkbCBRKFt2JX5fxKNWMJpLGxe_RB64cOyHRRtLROZ-EOFX1keA1Y5246sOk1xRTuiZYkJrwN9U5pYyvBGe_375Yn1WXKd3jMpoaE8zeV2esabqmZfV59W8TYrQesgsTCj26_rXZ1GgOfj-GOA8ujQnBZJB30x_YWmRcsg-L805Ft4wIUgraQbYG_XV5QGFnI3iP0hJ3bgf-MatL2OmyCUvWYbQoB6QHO4Y8FPe8R25CKlpIGWmYtI0fqnc9-GQvT_NFdfft-m7zY3X78_vN5uvtSnPS5pVpVaeMBcBtz5VoCMGEY0xox3tKuOl0UVrVa0GIwjVmArApWt1aQ6xiF9XNEWsC3Ms5uhHiXgZw8lEIcSshZqe9lYXPcWE2AgNvaF1IuhM1MKJbZUxbWF-OrHlRozXaTrl8xCvo65PJDXIbdlJ0vKmZKIDPJ0AMD4tNWY4uaes9TDYsSdK26TrCaEuLlRytOoaUou2fryFYHrohD92Qh27IUzdK5tPL9z0nnprA_gNqTLmQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2768813272</pqid></control><display><type>article</type><title>Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer</title><source>PubMed Central(OpenAccess)</source><creator>Khan, Iqra ; Masood, Nosheen ; Yasmin, Azra</creator><creatorcontrib>Khan, Iqra ; Masood, Nosheen ; Yasmin, Azra</creatorcontrib><description>ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to assess the role of four selected single nucleotide polymorphisms (SNPs) in ERCC5 and their linkage disequilibrium associated with survival analysis and clinical outcomes in breast cancer. Four SNPs (rs751402, rs17655, rs2094258, and rs873601) of the ERCC5 gene were analyzed using the PCR-RFLP technique, followed by sequencing in 430 breast cancer (BC) cases and 430 cancer-free individuals. Statistical analysis was performed using MedCalc 17 and SPSS version 24, while bioinformatic analysis of linkage disequilibrium was performed using Haploview software 4.2. Multivariate analysis showed that the rs751402 and rs2094258 polymorphisms were significantly associated with an elevated risk of BC (P &lt; 0.001), while the other two SNPs, rs17655 and rs873601, did not show any association (P &gt; 0.001). Survival analysis revealed that rs751402 and rs2094258 had longer overall survival periods (P &lt;0.001) than rs17655 and rs873601. Moreover, rs751402 and rs2094258 also had significantly longer overall survival (log-rank test, P &lt; 0.005) for all three survival functions (positive family history, ER+PR status, and use of contraceptives), while rs17655 and rs873601 did not show any significant association. Only rs873601 showed a strong negative correlation with all the chemotherapeutic groups. The current results suggest that variations in ERCC5 may contribute to BC development and that their genetic anomalies may be associated with cancer risk and may be used as a biomarker of clinical outcome.</description><identifier>ISSN: 2234-943X</identifier><identifier>EISSN: 2234-943X</identifier><identifier>DOI: 10.3389/fonc.2022.1091514</identifier><identifier>PMID: 36686735</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>breast cancer ; ERCC5 gene ; linkage disequilibrium ; Oncology ; polymorphism ; survival analyses</subject><ispartof>Frontiers in oncology, 2023-01, Vol.12, p.1091514-1091514</ispartof><rights>Copyright © 2023 Khan, Masood and Yasmin.</rights><rights>Copyright © 2023 Khan, Masood and Yasmin 2023 Khan, Masood and Yasmin</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c417t-d7b8bdeaa07f4b9611014001284f214d8c1107bfc911b05039a0dc1157ed1eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846539/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846539/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36686735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Iqra</creatorcontrib><creatorcontrib>Masood, Nosheen</creatorcontrib><creatorcontrib>Yasmin, Azra</creatorcontrib><title>Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer</title><title>Frontiers in oncology</title><addtitle>Front Oncol</addtitle><description>ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to assess the role of four selected single nucleotide polymorphisms (SNPs) in ERCC5 and their linkage disequilibrium associated with survival analysis and clinical outcomes in breast cancer. Four SNPs (rs751402, rs17655, rs2094258, and rs873601) of the ERCC5 gene were analyzed using the PCR-RFLP technique, followed by sequencing in 430 breast cancer (BC) cases and 430 cancer-free individuals. Statistical analysis was performed using MedCalc 17 and SPSS version 24, while bioinformatic analysis of linkage disequilibrium was performed using Haploview software 4.2. Multivariate analysis showed that the rs751402 and rs2094258 polymorphisms were significantly associated with an elevated risk of BC (P &lt; 0.001), while the other two SNPs, rs17655 and rs873601, did not show any association (P &gt; 0.001). Survival analysis revealed that rs751402 and rs2094258 had longer overall survival periods (P &lt;0.001) than rs17655 and rs873601. Moreover, rs751402 and rs2094258 also had significantly longer overall survival (log-rank test, P &lt; 0.005) for all three survival functions (positive family history, ER+PR status, and use of contraceptives), while rs17655 and rs873601 did not show any significant association. Only rs873601 showed a strong negative correlation with all the chemotherapeutic groups. The current results suggest that variations in ERCC5 may contribute to BC development and that their genetic anomalies may be associated with cancer risk and may be used as a biomarker of clinical outcome.</description><subject>breast cancer</subject><subject>ERCC5 gene</subject><subject>linkage disequilibrium</subject><subject>Oncology</subject><subject>polymorphism</subject><subject>survival analyses</subject><issn>2234-943X</issn><issn>2234-943X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkstqGzEYhYfS0oQ0D9BN0bIbO7rNRZtCMWkbCBRKFt2JX5fxKNWMJpLGxe_RB64cOyHRRtLROZ-EOFX1keA1Y5246sOk1xRTuiZYkJrwN9U5pYyvBGe_375Yn1WXKd3jMpoaE8zeV2esabqmZfV59W8TYrQesgsTCj26_rXZ1GgOfj-GOA8ujQnBZJB30x_YWmRcsg-L805Ft4wIUgraQbYG_XV5QGFnI3iP0hJ3bgf-MatL2OmyCUvWYbQoB6QHO4Y8FPe8R25CKlpIGWmYtI0fqnc9-GQvT_NFdfft-m7zY3X78_vN5uvtSnPS5pVpVaeMBcBtz5VoCMGEY0xox3tKuOl0UVrVa0GIwjVmArApWt1aQ6xiF9XNEWsC3Ms5uhHiXgZw8lEIcSshZqe9lYXPcWE2AgNvaF1IuhM1MKJbZUxbWF-OrHlRozXaTrl8xCvo65PJDXIbdlJ0vKmZKIDPJ0AMD4tNWY4uaes9TDYsSdK26TrCaEuLlRytOoaUou2fryFYHrohD92Qh27IUzdK5tPL9z0nnprA_gNqTLmQ</recordid><startdate>20230104</startdate><enddate>20230104</enddate><creator>Khan, Iqra</creator><creator>Masood, Nosheen</creator><creator>Yasmin, Azra</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230104</creationdate><title>Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer</title><author>Khan, Iqra ; Masood, Nosheen ; Yasmin, Azra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-d7b8bdeaa07f4b9611014001284f214d8c1107bfc911b05039a0dc1157ed1eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>breast cancer</topic><topic>ERCC5 gene</topic><topic>linkage disequilibrium</topic><topic>Oncology</topic><topic>polymorphism</topic><topic>survival analyses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Iqra</creatorcontrib><creatorcontrib>Masood, Nosheen</creatorcontrib><creatorcontrib>Yasmin, Azra</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Iqra</au><au>Masood, Nosheen</au><au>Yasmin, Azra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer</atitle><jtitle>Frontiers in oncology</jtitle><addtitle>Front Oncol</addtitle><date>2023-01-04</date><risdate>2023</risdate><volume>12</volume><spage>1091514</spage><epage>1091514</epage><pages>1091514-1091514</pages><issn>2234-943X</issn><eissn>2234-943X</eissn><abstract>ERCC5 is a DNA endonuclease and nucleotide excision repair gene; its mutations lead to a lack of activity by this enzyme, causing oxidative DNA damage. This study aimed to assess the role of four selected single nucleotide polymorphisms (SNPs) in ERCC5 and their linkage disequilibrium associated with survival analysis and clinical outcomes in breast cancer. Four SNPs (rs751402, rs17655, rs2094258, and rs873601) of the ERCC5 gene were analyzed using the PCR-RFLP technique, followed by sequencing in 430 breast cancer (BC) cases and 430 cancer-free individuals. Statistical analysis was performed using MedCalc 17 and SPSS version 24, while bioinformatic analysis of linkage disequilibrium was performed using Haploview software 4.2. Multivariate analysis showed that the rs751402 and rs2094258 polymorphisms were significantly associated with an elevated risk of BC (P &lt; 0.001), while the other two SNPs, rs17655 and rs873601, did not show any association (P &gt; 0.001). Survival analysis revealed that rs751402 and rs2094258 had longer overall survival periods (P &lt;0.001) than rs17655 and rs873601. Moreover, rs751402 and rs2094258 also had significantly longer overall survival (log-rank test, P &lt; 0.005) for all three survival functions (positive family history, ER+PR status, and use of contraceptives), while rs17655 and rs873601 did not show any significant association. Only rs873601 showed a strong negative correlation with all the chemotherapeutic groups. The current results suggest that variations in ERCC5 may contribute to BC development and that their genetic anomalies may be associated with cancer risk and may be used as a biomarker of clinical outcome.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36686735</pmid><doi>10.3389/fonc.2022.1091514</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2234-943X
ispartof Frontiers in oncology, 2023-01, Vol.12, p.1091514-1091514
issn 2234-943X
2234-943X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f4b40214690a46259a0c895a31c7bdd7
source PubMed Central(OpenAccess)
subjects breast cancer
ERCC5 gene
linkage disequilibrium
Oncology
polymorphism
survival analyses
title Correlation of ERCC5 polymorphisms and linkage disequilibrium associated with overall survival and clinical outcome to chemotherapy in breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A02%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20of%20ERCC5%20polymorphisms%20and%20linkage%20disequilibrium%20associated%20with%20overall%20survival%20and%20clinical%20outcome%20to%20chemotherapy%20in%20breast%20cancer&rft.jtitle=Frontiers%20in%20oncology&rft.au=Khan,%20Iqra&rft.date=2023-01-04&rft.volume=12&rft.spage=1091514&rft.epage=1091514&rft.pages=1091514-1091514&rft.issn=2234-943X&rft.eissn=2234-943X&rft_id=info:doi/10.3389/fonc.2022.1091514&rft_dat=%3Cproquest_doaj_%3E2768813272%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-d7b8bdeaa07f4b9611014001284f214d8c1107bfc911b05039a0dc1157ed1eb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2768813272&rft_id=info:pmid/36686735&rfr_iscdi=true